CAVALLARI, CRISTINA
CAVALLARI, CRISTINA
DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE
A study for the development of the mesalazine multiparticulate dosage forms for colon delivery in paediatric patients.
2008-01-01 A.G. Balducci; G. Corace; C. Cavallari; L. Rodriguez; P. Colombo; F. Sonvico; A. Rossi; G. Colombo
Anti-inflammatory formulation for topical use.
2006-01-01 L Rodriguez; A. M. Di Pietra; C. Cavallari; B. Luppi; C. Roberti
Apparatus for preparing solid forms with controlled release of active ingredients and method carriedout therein.
2004-01-01 L. RODRIGUEZ; M. CINI; C. CAVALLARi; G. MOTTA
Bimodal release of olanzapine from lipid microspheres
2010-01-01 A. Fini ; C. Cavallari; G. Ceschel; A. M. Rabasco
A cationic nanomicellar complex of the quaternary amphiphilic amine rc16+ with fenretinide as a new multitasking system for antitumor therapy
2019-01-01 Orienti I.; Cripe T.P.; Currier M.A.; Cavallari C.; Teti G.; Falconi M.
Certificati complementari di protezione dei medicinali: allineamento alle disposizioni comunitarie in materia e riassetto degli equilibri tra comparti dell'industria farmaceutica.
2004-01-01 P. Rampinelli; C. Cavallari; M. Cini
Characterization and taste-masking evaluation of acetaminophen granules: comparison between different preparation methods in a high shear mixer.
2004-01-01 ALBERTINI B.; CAVALLARI C.; PASSERINI N.; VOINOVICH D.; GONZALEZ RODRIGUEZ M.L.; MAGAROTTO L.; RODRIGUEZ L.
Cromolyn-crosslinked chitosan nanoparticles for the treatment of allergic rhinitis
2019-01-01 Angela Abruzzo, Teresa Cerchiara, Federica Bigucci, Giampaolo Zuccheri, Cristina Cavallari, Bruno Saladini, Barbara Luppi
Design of olanzapine/lutrol solid dispersions of improved stability and performances
2013-01-01 C. Cavallari; A. Fini; GC Ceschel
Diclofenac salts, part 6: Release from lipid microspheres
2011-01-01 A. Fini; C. Cavallari; A. M. Rabasco Alvarez; M. G. Rodriguez
Diclofenac salts, part 7: Are the pharmaceutical salts with aliphatic amines stable?
2012-01-01 Fini A; Cavallari C; Bassini G.; Ospitali F.; Morigi R.
Diclofenac Salts, VIII. Effect of the Counterions on the Permeation through Porcine Membrane from Aqueous Saturated Solutions
2012-01-01 A. Fini; G. Bassini; A. Monastero; C. Cavallari
Diclofenac Salts. V. Examples of Polymorphism among Diclofenac Salts with Alkyl-hydroxy Amines Studied by DSC and HSM
2010-01-01 A. Fini; C. Cavallari; F. Ospitali
Effect of Microwaves on a nimesulide/BCD solid dispersion
2011-01-01 Cristina Cavallari; Adamo Fini
Effect of Ultrasound on the Compaction of Ibuprofen/Isomalt Systems
2009-01-01 A. Fini ; C. Cavallari; F. Ospitali
Effect of ultrasound on the compaction of Indomethacin with lactose-containing excipients.
2004-01-01 A. Fini; C. Cavallari; B. Albertini; N. Passerini; L. Rodriguez
Enhanced Release of Indomethacin from PVP/Stearic Acid Microcapsules Prepared Coupling Co-freeze-drying and Ultrasound Assisted Spray-congealing Process.
2007-01-01 C. Cavallari; B. Luppi; A. M. Di Pietra; L. Rodriguez; A. Fini
Ex-vivo and in-vitro assessment of mucoadhesive patches containing the gel-forming polysaccharide psyllium for buccal delivery of chlorhexidine base
2015-01-01 Cavallari, Cristina; Brigidi, Patrizia; Fini, Adamo
EXTENDED ESD TECHNIQUE TO MODIFY THE PHYSICAL STATE OF DRUGS
2012-01-01 M. di Cagno; C. Cavallari; E. Aiudi; A. Fini
Formulazioni farmaceutiche per uso transdermico.
2006-01-01 C. Cavallari; B. Luppi; A.M. Di Pietra; L. Rodriguez